Abstract | PURPOSE: METHODS: RESULTS: CONCLUSIONS:
|
Authors | Kohei Nakachi, Junji Furuse, Taira Kinoshita, Mitsuhiko Kawashima, Hiroshi Ishii, Masafumi Ikeda, Shuichi Mitsunaga, Satoshi Shimizu |
Journal | Cancer chemotherapy and pharmacology
(Cancer Chemother Pharmacol)
Vol. 66
Issue 3
Pg. 527-34
(Aug 2010)
ISSN: 1432-0843 [Electronic] Germany |
PMID | 19967537
(Publication Type: Clinical Trial, Phase II, Journal Article)
|
Chemical References |
- Drug Combinations
- Deoxycytidine
- S 1 (combination)
- Tegafur
- Oxonic Acid
- Gemcitabine
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Chemotherapy, Adjuvant
(methods)
- Combined Modality Therapy
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Disease-Free Survival
- Drug Combinations
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Oxonic Acid
(administration & dosage)
- Pancreatic Neoplasms
(pathology, therapy)
- Survival Rate
- Tegafur
(administration & dosage)
- Treatment Outcome
- Gemcitabine
|